Copyright
©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Jul 26, 2017; 9(7): 583-593
Published online Jul 26, 2017. doi: 10.4330/wjc.v9.i7.583
Published online Jul 26, 2017. doi: 10.4330/wjc.v9.i7.583
Peripheral interventions and antiplatelet therapy: Role in current practice
Pahul Singh, Yenal Harper, Mohamed Morsy, Raza Askari, Rami N Khouzam, Department of Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN 38163, United States
Carrie S Oliphant, Methodist University Hospital, Memphis, TN 38104, United States
Carrie S Oliphant, Department of Clinical Pharmacy, University of Tennessee College of Pharmacy, Memphis, TN 38163, United States
Michelle Skelton, Department of Biology, Emory University, Atlanta, GA 30322, United States
Author contributions: All authors equally contributed to this paper with conception and design of the study, literature review and analysis, drafting and critical revision and editing, and final approval of the final version.
Conflict-of-interest statement: There is no conflict of interest associated with the senior author or any of the other coauthors. All authors contributed their efforts in this manuscript.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Rami N Khouzam, MD, FACP, FACC, FASNC, FASE, FSCAI, Associate Professor, Department of Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, 956 Court Avenue, Ste. A318D, Memphis, TN 38163, United States. khouzamrami@yahoo.com
Telephone: +1-901-4170809 Fax: +1-901-7475805
Received: January 31, 2017
Peer-review started: February 10, 2017
First decision: March 6, 2017
Revised: April 6, 2017
Accepted: April 23, 2017
Article in press: April 24, 2017
Published online: July 26, 2017
Processing time: 176 Days and 6.9 Hours
Peer-review started: February 10, 2017
First decision: March 6, 2017
Revised: April 6, 2017
Accepted: April 23, 2017
Article in press: April 24, 2017
Published online: July 26, 2017
Processing time: 176 Days and 6.9 Hours
Core Tip
Core tip: Peripheral arterial disease (PAD) is nearly a pandemic disorder which carries a high morbidity and mortality. Treatment includes risk factor modification, revascularization whenever feasible and medical management including antiplatelet therapy being a crucial element. Despite improvements in endovascular techniques and equipment for revascularization in PAD patients, current data regarding antiplatelet therapy in this population is limited. Our objective is to consolidate the current data on role and duration of antiplatelet and anticoagulant therapy in re-vascularized lower limb PAD patients.